Korea S.E.
06:00:00 2024-05-20 pm EDT
5-day change
1st Jan Change
13,830
KRW
+0.73%
-2.12%
-13.24%
HLscience Co., Ltd. authorizes a Buyback Plan.
The Board of Directors of HLscience Co., Ltd. has authorized a buyback plan on May 17, 2017.
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on September 30, 2022.
23-05-25
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on September 30, 2022.
23-05-25
CI
HLscience Co., Ltd.'s Equity Buyback announced on September 30, 2022, has expired with 153,589 shares, representing 2.94% for KRW 2,999.38 million.
23-05-24
CI
HLscience Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-20
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on September 30, 2022.
23-01-04
CI
HLscience Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
22-09-29
CI
HLscience Co., Ltd. authorizes a Buyback Plan.
22-09-29
CI
HLscience Co., Ltd.(KOSDAQ:A239610) dropped from S&P Global BMI Index
21-09-20
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on March 24, 2020.
20-09-24
CI
HLscience Co., Ltd's Equity Buyback announced on March 24, 2020, has expired with 60,620 shares, representing 1.2% for KRW 2,988.45 million.
20-09-23
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on March 24, 2020.
20-06-23
CI
HLscience Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
20-03-24
CI
HLscience Co., Ltd. authorizes a Buyback Plan.
20-03-23
CI
HLscience Co., Ltd.(KOSDAQ:A239610) added to S&P Global BMI Index
19-09-23
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on May 17, 2017.
17-11-17
CI
HLscience Co., Ltd.'s Equity Buyback announced on May 17, 2017, has expired with 82,172 shares, representing 1.6% for KRW 1,993.68 million.
17-11-16
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on May 17, 2017.
17-08-18
CI
HLscience Co., Ltd. announces an Equity Buyback.
17-05-17
CI
HLscience Co., Ltd. authorizes a Buyback Plan.
17-05-16
CI
HLscience Co., Ltd. has completed an IPO in the amount of KRW 40.80 billion.
16-10-27
CI
Health-Love Co., Ltd. has filed an IPO.
16-06-17
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-13.24% 51.41M +17.57% 8.44B +3.57% 7.47B +5.65% 6.31B -5.28% 3.77B -2.14% 1.33B -28.64% 1.09B +15.61% 988M -8.92% 927M -17.11% 801M
Special Foods & Wellbeing Products
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
HLSCIENCE CO., LTD. 